Third Time's A Charm: FDA Approves Melanoma Drug After Roller Coaster Of Rejections

Third Time's A Charm: FDA Approves Melanoma Drug After Roller Coaster Of Rejections Adults with unresectable advanced cutaneous melanoma will now be able to take a combination of Tudriqev and Opdivo. The approval gives more patients "a fighting chance," said Karim Mikhail, acting director of the FDA's Center for Biologics Evaluation and Research. Also: The FDA has approved a drug for narcolepsy type 1. https://kffhealthnews.org/morning-breakout/pharma-and-tech-080726/